2019 Updated diagnostic criteria and disease severity classification for TAFRO syndrome

被引:0
|
作者
Yasufumi Masaki
Hiroshi Kawabata
Kazue Takai
Norifumi Tsukamoto
Shino Fujimoto
Yasuhito Ishigaki
Nozomu Kurose
Katsuhiro Miura
Shigeo Nakamura
Sadao Aoki
机构
[1] Kanazawa Medical University,Department of Hematology and Immunology, Medicine
[2] Niigata City General Hospital,Division of Hematology
[3] Gunma University Graduate School of Medicine,Department of Medicine and Clinical Science
[4] Kanazawa Medical University,Medical Research Institute
[5] Kanazawa Medical University,Department of Pathology and Laboratory Medicine
[6] Nihon University School of Medicine,Department of Hematology and Rheumatology
[7] Nagoya University Graduate School of Medicine,Department of Pathology and Biological Response
[8] Niigata University of Pharmacy and Applied Life Sciences,Department of Pathophysiology, Faculty of Pharmaceutical Sciences
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:155 / 158
页数:3
相关论文
共 50 条
  • [41] TAFRO syndrome: A disease that known is half cured
    Chen, Tingting
    Feng, Chun
    Zhang, Xinyou
    Zhou, Jihao
    HEMATOLOGICAL ONCOLOGY, 2023, 41 (03) : 310 - 322
  • [42] Diagnostic criteria for multiple sclerosis updated
    不详
    FUTURE NEUROLOGY, 2006, 1 (01) : 11 - 11
  • [43] IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE WITH TAFRO SYNDROME AND SJOGREN SYNDROME
    Durant, Catherine
    Balasubramanian, Shailesh
    CHEST, 2022, 162 (04) : 1020A - 1021A
  • [44] Systematic Review of the Diagnostic Criteria and Severity Classification for Fuchs Endothelial Corneal Dystrophy
    Oie, Yoshinori
    Yamaguchi, Takefumi
    Nishida, Nozomi
    Okumura, Naoki
    Maeno, Sayo
    Kawasaki, Ryo
    Jhanji, Vishal
    Shimazaki, Jun
    Nishida, Kohji
    CORNEA, 2023, 42 (12) : 1590 - 1600
  • [45] Tafro Syndrome without Pathological Evidence Consistent with Castleman Disease: A Subtype of Tafro or a Distinct Disease Entity?
    Li, Siyuan
    Gao, Yuhan
    Dang, Yue
    Zhang, Lu
    Li, Jian
    BLOOD, 2024, 144 : 6298 - 6299
  • [46] Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease
    Hiroya Ichikawa
    Kimikazu Yakushijin
    Keiji Kurata
    Takahiro Tsuji
    Naoko Takemoto
    Miki Joyce
    Yuri Okazoe
    Ruri Takahashi
    Sakuya Matsumoto
    Rina Sakai
    Akihito Kitao
    Yoshiharu Miyata
    Yasuyuki Saito
    Shinichiro Kawamoto
    Katsuya Yamamoto
    Mitsuhiro Ito
    Tohru Murayama
    Hiroshi Matsuoka
    Hironobu Minami
    Bone Marrow Transplantation, 2024, 59 : 518 - 525
  • [47] Utility of the refined EBMT diagnostic and severity criteria 2023 for sinusoidal obstruction syndrome/veno-occlusive disease
    Ichikawa, Hiroya
    Yakushijin, Kimikazu
    Kurata, Keiji
    Tsuji, Takahiro
    Takemoto, Naoko
    Joyce, Miki
    Okazoe, Yuri
    Takahashi, Ruri
    Matsumoto, Sakuya
    Sakai, Rina
    Kitao, Akihito
    Miyata, Yoshiharu
    Saito, Yasuyuki
    Kawamoto, Shinichiro
    Yamamoto, Katsuya
    Ito, Mitsuhiro
    Murayama, Tohru
    Matsuoka, Hiroshi
    Minami, Hironobu
    BONE MARROW TRANSPLANTATION, 2024, 59 (04) : 518 - 525
  • [48] Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease
    Epson, Erin
    Cassidy, Maureen
    Marshall-Olson, Angela
    Hedberg, Katrina
    Winthrop, Kevin L.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 74 (01) : 98 - 100
  • [49] Alzheimer's disease - Recent biomarker developments in relation to updated diagnostic criteria
    Hoglund, Kina
    Fourier, Anthony
    Perret-Liaudet, Armand
    Zetterberg, Henrik
    Blennow, Kaj
    Portelius, Erik
    CLINICA CHIMICA ACTA, 2015, 449 : 3 - 8
  • [50] CHRONIC ACTIVE LIVER-DISEASE - CLASSIFICATION AND DIAGNOSTIC CRITERIA
    ALARCONSEGOVIA, D
    VELAZQUEZ, F
    KERSHENOBICH, D
    GUEVARA, L
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1972, 24 (03): : 297 - +